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"No man can reveal to you aught but that which 
already lies half asleep in the dawning of your knowledge. 
The teacher who walks in the shadow of the temple, among 
his followers, gives not of his wisdom, but of his faith 
and lovingness. If he is indeed wise, he does not bid 
you to enter the house of his wisdom, but rather leads 
you to the threshold of your own mind," 
-Kahlil Gibran 
The Prophet 
This thesis is dedicated to those who have inspired 
me in the spirit of the above passage. 
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INTRODUCTION 
The blood vessels of man serve to transport cellular 
elements, electrolytes, proteins, carbohydrates, lipids, 
and water to the tissues. Since over 9k% of the noncellular 
component of blood is water, such an aqueous medium would 
not be especially suitable to carry water-insoluble lipids. 
Yet these lipids are essential in metabolism as substrates 
for energy and also as building blocks for highly specific 
biological membranes, Man and other animals have developed 
a water-soluble, protein-bound form of these lipids for 
transportation in the blood which have been appropriately 
called plasma lipoproteins. 
Within the past 20 years extensive research has been 
carried out on lipoproteins and their interaction with 
vessel walls, because lipoproteins have been implicated 
as being a causal factor in the pathogenesis of arterio¬ 
sclerosis, While arteriosclerosis is not completely 
understood, certain facts and observations have resulted 
in the "lipid filtration-injury theory" or "combination 
-1- 
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theory" to explain its pathogenesis. This theory 
assumes that only small molecules such as water, glucose, 
free fatty acids, electrolytes, etc, are able to penetrate 
the intact endothelial surface of the vessel wall either 
by pinocytosis or by squeezing through endothelial 
junctions. Because of their large size, lipoproteins can 
not penetrate the intact endothelial surface of the artery. 
If, however, the endothelial surface of the vessel is 
subjected to an injury, physically or chemically induced, 
the integrity of this barrier to the passage of large 
proteins and lipoproteins is lost. These large molecules 
can then find passage into the subendotheliai layers of 
the vessel wall* Here the lipoproteins encounter the 
structural elements, fibrillar proteins, and the ground 
substance of the vessel wall with which they may physically 
or chemically interact. The cells in this compartment may 
be active in phagocytizing the lipoprotein. Such cells 
are the well-known lipophages or "foam cells" of the early 
arteriosclerotic lesion. There follows a proliferative 
process of fibrosis with deposition of collagen, hemorrhage, 
calcification, ulceration, and thrombosis. This process 
can eventually lead to occlusion of the vessel wall. 
As a theory the "combination theory" may explain 
many observations in the pathogenesis of arteriosclerosis. 
However, evidence for the molecular basis upon which 
-2“ 
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lipoproteins might interact with arterial wall connective 
tissue, including its ground substance, is nebulous. 
Whether such interactions are crucial in initiating the 
arteriosclerotic process is also not known. The question 
arises as to why lipoproteins are unique in their abilty 
to initiate it. Is it the size of the lipoprotein 
molecule that gives it this property, or could it be the 
physiochemical nature of the molecule which accounts 
for its behavior in injured arterial vessels? 
It has been suggested that the large size of the 
lipoprotein molecule is responsible for its being trapped 
in the vessel wall. However, it is also known that lipo¬ 
proteins will form insoluble precipitates with the mucopoly' 
saccharides extracted from the ground substance of arterial 
3 
walls. There is no concrete evidence to refute the idea 
that there exist critically charged species of lipoprotein 
molecules which allow them to bind to the ground substance 
of the vessel wall, thus keeping them in the intima to be 
subsequently phagocytized. 
The present study examines the effect of altering 
the surface charge of the lipoprotein molecule in relation 
to its permeation through the artery wall. If the 
permeability of the unmodified lipoprotein molecule 
through the vessel wall is the same as that of the modified 
"3- 

lipoprotein molecule, which is essentially the same size 
and shape as the unmodified lipoprotein molecule but 
with an altered surface electrical charge, it could be 
concluded that the size and shape of the molecule are 
important in retarding the passage of the lipoprotein 
through the vessel wall. However, if the modified lipo¬ 
protein with its uncharged surface has a markedly different 
permeability through the vessel wall than the unmodofied 
lipoprotein, then it can be postulated that, at least 
in the conditions of the experiment, the charged character 
of the lipoprotein molecule may be critical in determining 
the permeability of these large proteins through vessel 
walls, 
-4- 
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CHOLESTEROL AND BETA-LIPOPROTEINS IN ARTERIOSCLEROSIS 
There is a large body of evidence that cholesterol 
and its primary plasma transporting protein* beta- 
lipoprotein or low density lipoprotein, play a primary 
role in the development of arteriosclerosis. This 
evidence has come from a number of different sources- 
epidemiological, clinical, experimental, and pathological. 
The Framingham Study, an epidemiological study of 
risk factors in coronary heart disease, showed that elevated 
serum cholesterol levels were the most important determining 
4 
factor as to who would develop ischemic heart disease. 
It was assumed that the vast majority of the ischemic 
heart disease was on an arteriosclerotic basis. The 
Frederickson classification of the hyperlipidemias on a 
genetic basis has provided further clinical evidence 
that hypercholesterolemia and hyperbeta-lipoproteinemia 
are important predisposing factors in coronary artery 
5 
disease» 
Analytical studies of the chemical composition of 
arteriosclerotic lesions, foam cells, and fatty streaks 
have in some instances shown a striking similarity to the 
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chemical composition of beta-lipoproteins. It seems likely 
that it is only the beta-lipoproteins which are agents 
in initiating a proliferative response in the intima 
of the vessel wall. Watts used flourescent labeled 
antibodies against beta-lipoproteins to show that these 
were the compounds found in foam cells and arteriosclerotic 
7 
lesions. Getz et al. demonstrated a localization 
8 
of beta-lipoprotein antigen in foam cells. 
That most of the lipid found in these lesions is 
cholesterol suggests faulty beta-lipoprotein metabolism, 
since beta-lipoproteins transport 75% of the plasma 
cholesterol. The reason why cholesterol is the predominant 
lipid that accumulates, and not triglycerides or some 
other lipid, may be explained by the enzymes present in 
the vessel wall. Lipases are known to exist in the 
9 
vessel wall which clear triglycerides from lipoproteins. 
This might allow individual triglyceride molecules to 
diffuse freely through the vessel wall. The triglyceride¬ 
carrying lipoprotein, now free of its lipid, could 
readily diffuse through the vessel wall. However, the 
arterial vessel wall does not seem to have the enzymes 
needed to clear cholesterol and cholesterol esters from 
beta-lipoproteins. Should the beta-lipoproteins bind to 
some component of the ground substance, the beta-lipoprotein 
with its cholesterol and cholesterol esters would be rendered 
immobile in the intima. Defense mechanisms of the body 
may then be called upon to react with these entrapped 
-6- 
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molecules. Phagocytosis of the lipoproteins hy cells 
in the vessel wall starts the reactive proliferative 
response seen in arteriosclerosis. 
In some experimental animals arteriosclerosis can 
he produced by elevating the animal's serum beta-lipo- 
proteins. In these animals the rate of formation of 
these lesions is proportional to the increase in the 
10 
serum lipoprotein level. 
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THE CONNECTIVE TISSUE OF THE VESSEL WALT. 
The connective tissue of the arterial intima is 
compartmentalized between the endothelial cells that 
line the vessel wall and the musculature of the media, 
as shown in figure 1. 
There are three types of structural elements in the 
arterial connective tissue- cells, fibrillar proteins, 
and compounds in the amorphous ground substance. These 
fibers and compounds in the amorphous ground substance 
could conceivably interact chemically with beta-lipoproteins 
-8- 

to form insoluble precipitates. Some of the cells are 
also capable of phagocytizing lipoproteins and lipids. 
Thus if the beta-lipoprotein can penetrate the endothelial 
cells and. find passage into the intima, there is potential 
for both cellular and chemical interaction with the 
connective tissue of the intima* It is likely that 
some of these interactions are involved in the patho¬ 
genesis of arteriosclerosis* 
Cells of the Intima 
Fibroblasts, macrophages, wandering cells (probably 
capable of differentiating into smooth muscle cells or 
phagocytes), fat cells, and blood elements are the cells 
that inhabit the intima of a large artery of man. In 
terms of material production the fibroblast is by far 
the most important, since this versatile cell has the 
enzymatic machinery to produce the fibrillar proteins as 
11 
well as the compounds of the ground substance. 
One of the enigmas in the investigation of arterio¬ 
sclerosis is in defining which cells are responsible 
for phagocytizing lipid which has infiltrated into the 
intima. Evidence suggests that smooth muscle cells 
(wandering myoblasts of multipotential differentiation), 
migrate from the media into the intima where they are 
capable of differentiating into phagocytes which can 
ingest lipid and lipoproteins that have accumulated in 
“9“ 
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the intimao It is believed that these cells can also 
differentiate into fibroblasts and lay down collagen 
12 
in response to the insult of lipid accumulation. 
Fibrillar Proteins of the In time. 
There are three distinct fibrillar proteins in the 
connective tissue of the human artery- collagen, elastin, 
and reticulin. Collagen and elastin are the most 
important, since they each comprise about 25% of the dry 
13 
weight of large arteries® Gerontologists have shown 
great interest in these proteins, because molecular 
changes in them are believed to be important in the 
ageing of organisms. Since arteriosclerosis is a prominent 
disease in the aged, the question arises as to whether 
the changes in the fibrillar proteins that occur with 
age predispose to the development of arteriosclerosis. 
Collagen is the major supporting structure of the 
body, and its role as such can be attributed to its 
high tensile strength. The molecular make-up of this 
molecule is helpful in explaining this important property. 
Collagen is composed of a number of subunits which 
have an inherent proclivity to aggregate with each other. 
These subunits are the tropocollagen molecule which 
itself is composed of three peptide strands. Each of 
these strands is about 1,000 amino acids, and two of the 
three strands are identical. The three peptide strands 
-10- 

are cross-linked by intramolecular covalent bonds. 
The amino acid hydroxylysine is unique to collagen,, 
and along with lysine these two amino acids are responsible 
for the intramolecular cross-linkings between the peptide 
strands in the tropocollagen molecule and the inter- 
molecular cross-linkings between tropocollagen molecules. 
Oxidative deamination of lysine and hydroxylysine yield 
the semialdehyde of ^aminoadipic acid taminohydroxyadipic 
acid, respectively. Both of these comnounds can undergo 
14 
aldol condensations to form these covalent cross-linkages. 
It is interesting to note that collagen has a variable 
carbohydrate content depending on its age and location 
in the body. Sugar groups attached to hydroxylysine 
in ester linkage prevent the formation of the aldol bond 
15 
needed to form the cross-links. 
Experimental lathyrism has demonstrated that the 
intermolecular cross-links of the collagen molecule 
are primarily responsible for the structural stability 
16 
of the moleculeo However there are other contributing 
forces. Hydrogen bonds, Van der Waal's forces, and 
ionic bonds between side chains of polar amino acids all 
strengthen the mechanical stability of the individual 
tropocollagen molecules. Additional intermolecular 
stabilization is provided by water molecules and the 
17 
amorphous ground substance. 
-11- 

Unlike collagen fibers elastin fibers show a high 
degree of extensibility. Large arterial conduits contain 
more elastin than arterioles* The high elastin content 
of large arteries gives them a snap-like action which 
pushes blood forward in diastole in the absence of any 
contractile forces of the heart. 
The resiliency of elastin can be appreciated by 
examining its molecular structure. Unique to the 
elastin molecule are the amino acids desmosine and isodes- 
mosine® Containing a pyridine nucleus alkylated at the 
nitrogen atom and three of the ring carbon atoms* both 
amino acids form cross-links at each of these branched 
18 
chains® 
Amino acid analysis of elastin shows a high 
percentage of apolar amino acids. It is thought that 
the many apolar amino acids form stable hydrophobic 
interactions when the elastin molecule is stretched. 
Thus to re-establish the more stable configuration of 
maximal hydrophobic interactions, the molecule spon- 
19 
taneously returns to its resting state when stretched. 
The highly apolar nature of the elastin molecule 
explains the affinity that elastin has for lipids and 
lipoproteins. The yellow streaking that is so often 
found in the elastin of elderly people is from lipid 
deposition. It is also noteworthy that elastin has the 
property of calcifying with age. That mucopolysaccharides 
with their anionic sulfate groups may be important in 
-12- 
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1 
attracting calcium ions to the vicinity of the elastin 
20 
molecule has been postulated, 
Reticulin, found only in small quantities in the 
arterial intima, branches characteristically to form 
a mesh of fine reticular fibers. The fibers are 85% 
protein™ the amino acid sequence being similar to that 
in collagen, 10% fatty acids, and 5% glucides. 
Controversy exists as to whether these fibers originate 
from collagen and collagen precursors, or whether their 
21 
synthesis is totally independent of collagen. 
Ground Substance of the Intima 
The ground substance of the intimal connective 
tissue consists of two groups of complex macromolecules, 
the mucopolysaccharides and the glycoproteins. 
The mucopolysaccharides are a heterogeneous group 
of repeating disaccharide units of a hexosamine, which 
may or may not be sulfated, and a hexuronic acid. These 
polymeric chains are linked to a core protein and have a 
6 22 
molecular weight of 1™4 x 10 grams. Much has been 
done in characterizing the carbohydrate portion of 
these complexes, but little is known about the core 
protein. It appears that more than one different muco™ 
polysaccharide can attach to the same core protein 
molecule. The linkage of the carbohydrate to the protein 
23 
is through serine and xylose. 
-13- 
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The hexosamine and hexuronic acids are synthesized 
from glucose and then attached to growing chains of 
mucopolysaccharides by uridine nucleotides. The 
hexosamine molecules are formed by the amination of 
hexose groups, the amine groups being donated by 
24 
glutamine. Sulfation occurs through a donor 
3-r>hosphoadenosine”5”"Phosphosulfate molecule. The 
25 
sulfur atom comes from sulfur containing amino acids. 
Table 1 lists the mucopolysaccharides that are found 
in the ground substance of human arterial connective 
tissue. 
TABLE 1-Mucopolysaccharides of the human artery 
1. Chondroitin sulfate A 
2, Chondroitin sulfate B 
3® Chondroitin sulfate C 
4. Hyaluronic acid 
5® Heparin 
6. Heparitin sulfate 
7. Keratosulfate 
Chondroitin sulfate B and heparitin sulfate are the 
predominant mucopolysaccharides of the vessel intima® 
About 0.5% of the dry weight of aorta is mucopolysacch- 
26 
arides• 
The metabolism of the mucopolysaccharides appears 
to be under hormonal control® Hypothyroid states cause 
an increase in hyaluronic acid formation and a decrease 
in chondroitin sulfate formation. Corticosteroids depress 
2? 
all mucopolysaccharide production. Sex hormones have 
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a marked influence on the metabolism of mucopolysaccharides 
in rat aorta9 Testosterone caused a 20% increased 
synthesis of rat aortic mucopolysaccharides in incubation 
media; whereas estradiol caused a marked inhibition of 
28 
mucopolysaccharide synthesis• 
Mullinger and Manley correlated vessel wall muco- 
polysaccharide profiles of various animal species based 
on uronic acid content to the susceptibility of the 
animal to arteriosclerosis® They found that in the most 
susceptible animal the uronic acid content was ?«6 ug./mg. 
of dry weight aorta, and in the least susceptible 
29 
1,07 uge/mg» of dry weight aorta® Rats and hamsters 
had the lowest mucopolysaccharide content per unit 
weight of arterial tissue, and these are two animals in 
which it is extremely difficult to induce arteriosclerotic 
changes through prolonged lipemia* Likewise, the chicken 
and the pig had high levels of mucopolysaccharides in 
their intimal ground substance, and these are animals in 
which it is quite easy to produce experimental arterio- 
30 
sclerotic changes through lipemia* 
Up to the age of 30 there is a progressive increase 
in the mucopolysaccharide content of the ground substance 
in human arteries, most of which is heparitin sulfate 
and chondroitin sulfate. In the early lesions of arterio¬ 
sclerosis there is an increase in the quantity of 
mucopolysaccharides, but with the onset of fibrous plaques 
"15" 
•V 
and more extensive lesions, there is a decrease in the 
31 
quantity of mucopolysaccharides* 
Forman and his coworkers demonstrated that sulfated 
mucopolysaccharide production was increased at sites of 
arteriosclerotic lesions. They gave sulfate labelled 
35 
with S to a group of 15 rabbits. Arteriosclerosis 
was then induced in 7 of the rabbits by cholesterol 
feeding. After 12 weeks the sulfate concentration in the 
arterial tissue of the arteriosclerotic animals was 
greater than in the controls. Arterial autoradiograms 
showed that the greatest localization of sulfur was in 
32 
arteriosclerotic lesions. 
Much less is known about the glycoproteins of the 
connective tissue matrix. Structurally they contain 
no uronic acids or sulfate esters. They consist of 
proteins linked to acetylhexosamin.es, neutral sugars, 
various derivatives of N-acetylhexuronic acid, and sialic 
acid. Unlike other connective tissue components, the 
33 
glycoproteins are highly antigenic. Murata and Kink 
compared sialic acid content of normal and arterio- 
sclerotic aortas. They found that in the arteriosclerotic 
aortas there is a decrease in the amount of sialic 
34 
acid compared to the uninvolved aortas. 
-16- 

THE INTERACTION OF BETA-LIPOPROTEINS WITH 
SULFATED MUCOPOLYSACCHARIDES 
In 1949 Faber showed that cholesterol was deposited 
in regions of human aortas that had a high sulfate- 
containing polyuronidecontent (sulfated mucopolysacch- 
35 
a.rides). 
In 1952 Walton demonstrated that sulfated muco¬ 
polysaccharides such as heparin and dextran sulfate formed 
36 
insoluble complexes with fibrinogen, Oncley thought 
that this precipitation was the result of an electrostatic 
interaction between the negatively charged sulfate groups 
of the sulfated mucopolysaccharides and the positively 
charged surface groups of the large fibrinogen molecule, 
Oncley was interested in finding a technique for 
separating beta-lipoproteins from other plasma proteins. 
Since the beta-lipoprotein molecule is also large and 
has a positively charged surface at physiologic pH, he 
investigated whether beta-lipoproteins also share the 
property of precipitating mucopolysaccharides. In 
1957 Oncley made the observation that low molecular 
-17- 
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weight dextran sulfate formed soluble complexes with 
beta-lipoproteins» and high molecular weight dextran 
sulfate formed insoluble precipitates with beta-lipo- 
37 
proteins» 
The observation that beta-lipoproteins could 
precipitate with sulfated mucopolysaccharides was of 
signifigant interest to those studying arteriosclerosis* 
Since the arterial intima contains high molecular 
weight , sulfated mucopolysaccharides, it was postulated 
that these sulfated compounds might precipitate beta- 
lipoproteins in the vessel wall should the beta-lipoprotein 
gain access to the subendothelial space* If this were 
true, the entrapment of the beta-lipoprotein molecule 
in the intima bv this mechanism might be an important 
38,39 
consideration in the arteriosclerotic process* 
Further work on the nature of the interaction 
between beta-lipoproteins and sulfated mucopolysaccharides 
was done by Nishida and Cogan in 1970* They showed 
that succinylation or acetylation of beta-lipoproteins 
would render the modified beta-lipoprotein unable to 
40 
complex with or precipitate dextran sulfate. 
Succinylation of beta-lipoproteins is thought to 
change the charge of the molecule by reacting succinate 
groups at positively charged amino groups of the peptide 
portion of the molecule0 These positively charged amino 
groups are on the surface of the molecule, and because 
-18 

of this sterically favorable location, it is no surprise 
that large negatively charged species such as sulfated 
mucopolysaccharides will precipitate the parent molecule 
by electrostatic forces, (see figure 2) 
+ so4 - MPS - (S04)y 
"f “* 
LP - NH3*9,S04 - MPS - (S04)y 
FIGURE 2- The electrostatic interaction of beta-lipo- 
proteins (LP) and sulfated mucopoly¬ 
saccharides (MPS) 
The many positively charged amino groups on the lipo¬ 
protein molecule and the many negatively charged sulfate 
groups on the sulfated mucopolysaccharide allows for 
both intermolecular and intramolecular interactions. 
However, succinylation of the beta-lipoprotein 
drastically changes this favorable charged environment 
for the precipitation of sulfated mucopolysaccharides 
by binding to the nitrogen of the reactive amino 
41 
groups, (see figure 3) 
LP - 
Figure 3” Succinylation of beta-lipoprotein 
(NH3)n x C 
0 
LP-(NH-CQ-CH2CH2COQ) 
X 
(NH- 
n-x 
(NH3)x - LP - NH3 
♦ 
(NH3)x - 
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The nitrogen of the amino group in the modified 
beta-lipoprotein is now uncharged, and thus the electro¬ 
static attraction between it and a positively charged 
species is decreased. This would explain why the 
modified beta-lipoprotein does not react with sulfated 
mucopolysaccharides in the test tube, 
Margolis and Langdon estimated that a beta-lipo¬ 
protein molecule, having a molecular weight of about 
2.5 x 10^ grams, has 1200 positively charged groups and 
1160 negatively charged groups at its isoelectric point. 
This would mean that at a pH of 7,40 there would be about 
42 
1100 positively charged amino groups, Nishida and 
Cogan showed that by succinylating only 5% of these 
positively charged amino groups of the beta-lipoprotein 
molecule, complex and precipitate formation with dextran 
sulfate, and presumably other sulfated mucopolysaccharides, 
40 
could be prevented. 
Modification of the beta-lipoprotein by succinyl- 
ation only slightly increases its molecular weight. 
Assuming all 1200 positively charged amino groups were 
succinylated at pH 7,40, the molecular weight would 
increase by ,12 x 10 grams/mole, a 5% increase. Thus 
it is unlikely that any differences in the behavior of 
these two molecules could be attributed to differences 
in their size or molecular weight. 
-20- 
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EXPERIMENTAL DESIGN 
In 1950 Wilens performed a very simple experiment 
to determine the permeability of various plasma 
A3 
components through human arteries* He took iliac 
vessels from autopsy cases within 24 hours of death, sealed 
one end of the vessel by inserting and tying a glass rod, 
and then cannulated the other end of the vessel with 
a glass tube* Human plasma was then added into the vessel 
lumen, and the composition of the filtrate that was 
filtered atvarious pressures was determined, Wilens 
discovered that while very little cholesterol (an 
indirect measurement of beta-lipoprotein) was found in 
the filtrate even at pressures as high as 320 mm, of 
Hg, as much as 30% of the cholesterol was unaccounted for 
in the filtrate and the remaining plasma in the lumen 
after 2.4 hours. This meant that the cholesterol and 
its transport protein were somewhere in the vessel wall» 
To test the permeability of the succinylated 
(modified) and the native (unmodified) lipoprotein 
through the vessel wall, a method similar to that used 
21- 
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by Wilens was employed in the present experiments. Both 
common carotid arteries were taken from autopsies no 
more than 24 hours after death. The common carotid 
arteries were used because they have no branches and 
because they usually do not demonstrate far advanced 
arteriosclerotic lesions. The vessels were stripped 
of their adventitia and washed with 0.9% sodium 
chloride solution to assure that the vessels were devoid 
of any contaminating material. This process was quite 
satisfactory, for cholesterol determinations on these 
washings were zero. 
A short glass rod of slightly smaller diameter 
than the vessel was inserted 5 mm. into one end of the 
vessel, and coarse thread was securely tied around the 
vessel upon the glass rod to make as tight a seal 
as possible. 
The vessel was cut to 2.5 cm., and the other end 
of the vessel was cannulated with a 5 ml. pipette. 
Leaks were tested for by submerging the vessel in water 
and subjecting it to a pressure of 300 mm. Hg pressure. 
Only vessels which could maintain this pressure for 5 
minutes were used. 
The same procedure was then carried out on the other 
carotid segment. The open ends of the pipettes were 
connected to a T-tube, and the other end of the T-tube 
was connected to a bulb-operated sphygmomanometer. Both 
vessels were then put into glass tubes containing 
-22- 
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0.9% sodium chloride solution, (see figure 4) 
Three mis. of the unmodified lipoprotein solution 
were put into one pipette, and three mis. of the modified 
lipoprotein solution were put into the other pipette. 
Small magnetic stirrers were added to each glass 
container, and the bathing solutions were gently stirred. 
The pressure was then raised to 300 mm. Hg and was kept 
there for 24 hours. The experiment was carried out at 
room temperature. 
All vessels were cut to 2.5 cm. and placed in 20 
mis. of 0.9% sodium chloride solution except on trial 1. 
In this trial 30 mis. of distilled water were used as the 
bathing solution, and the vessels used were cut to 5 
cm. in length. Also only 2 mis. of lipoprotein solution 
were put into each pipette in trial 1. 
After 24 hours the pressure was released. The 
volume and cholesterol content in each of the vessels 
and in each of the bathing solutions was then determined. 
Frozen sections of each of the vessels following the 24 
hour exposure to the lipoprotein solutions, as well 
as control sections on vessel segments not exposed to 
the solutions in the pressurized in vitro system, were 
obtained. These were cut at 15-20 u, after the vessels 
were fixed in formalin for 48 hours. The frozen sections 
were stained with Sudan IV by a modification of the 
44 
technique used by Putt and Chiffelle. 
-23- 

Thus the experiment utilized pieces of vessel from 
the same person, of the same dimensions, and with the same 
amount of arteriosclerotic change. The vessels were 
exposed to the same amount of lipoprotein at the same 
pressure for the same amount of time. The only difference 
was in the nature of the lipoprotein solution in each 
vessel. 
-24- 

Figure 4- EXPERIMENTAL APPARATUS 
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Preparation of beta-lipoprotein solutions 
Beta-lipoproteins were separated from four liters 
of pooled, human A.C.D. plasma by the following method. 
Calcium chloride was added to precipitate the fibrinogen. 
The clotted fibrinogen was removed by filtration. Carbowax 
45 
was then added to precipitate the plasma globulins. 
The precipitate was redissolved, and the carbowax was 
removed by multiple washings in water at low ionic 
strength, leaving only the plasma proteins in solution. 
The low density, beta-lipoproteins were finally isolated 
by ultracentrifugation for 18 hours at 38,000 r.p.m. 
in 10% saline, (density-1.063) 
Twenty-eight mis. of beta-lipoprotein were obtained 
by this technique. Electrophoresis of this fraction 
on cellulose acetate strips gave a single, sharp band. 
Ten mis. of this beta-lipoprotein fraction were 
41 
succinylated by the method suggested by Klotz. One 
and a half grams (.01 moles) of succinic anhydride were 
slowly added to 10 mis. of the beta-lipoprotein in 25 
mis, of distilled water. The pH of the solution was 
monitored electronically, and as the succinic anhydride 
was added the pH was kept between 7.0-8.0 by the addition 
of 10 M sodium hydroxide. When the succinylation was 
completed, the solution was dialyzed against cold, 
running water for 24 hours. The final volume was 54 mis., 
-26- 
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c 
and the pH of the solution was adjusted to 7.40. Five 
hundred milligrams of sodium chloride were added to 
make the solution 0,9# sodium chloride. 
Ten mis. of the unmodified stock solution were then 
diluted to 54 mis, v/ith distilled water, and the pH of 
this solution was adjusted to 7»40. Five hundred 
milligrams of sodium chloride were added to this solution 
to make it also physiologic with respect to salt 
concentration. 
Total cholesterol concentrations of the modified 
and unmodified solutions were done by the Sperry and 
46 
Brand method. The cholesterol concentrations of the 
prepared solutions were: 
UNMODIFIED BETA-LIPOPROTEIN 1175 mg.# 
MODIFIED BETA-LIPOPROTEIN 1175 mg,# 
These two solutions were used on trials 1-7. After the 
seventh trial new solutions were made by the same 
procedure as described above. These solutions were 
used in trials 8-13. The total cholesterol concentrations 
of these solutions were s 
UNMODIFIED BETA-LIPOPROTEIN 1025 mg.# 
MODIFIED BETA-LIPOPROTEIN 1050 mg.# 
Electrophoresis on cellulose acetate strips showed 
that the unmodified beta-lipoprotein migrated toward the 
anode; whereas the modified beta-lipoprotein migrated 
toward the cathode, (see figure 5) 
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Figure 5“ Electrophoresis of unmodified and modified 
beta-lipoprotein fraction on cellulose 
acetate strips. 

When 0.1 mis. of the sulfated mucopolysaccharide 
heparin (1,000 units/ml.) were added to the unmodified 
beta-lipoprotein, a precipitate was observed; but no 
precipitate appeared when 0.1 mis. of heparin were 
added to 0.1 mis. of the modified beta-lipoprotein. 
This confirmed the expected behavior of the two beta- 
lipoproteins in. the presence of sulfated mucopoly¬ 
saccharides, 
Nishida and Cogan found that if at least 5%> of the 
free amino groups of the beta-lipoprotein molecule were 
succinylated at pH 7.40, this modified beta-lipoprotein 
40 
would not precipitate dextran sulfate. They correlated 
the ratio (moles of succinic anhydride/moles of lysine 
in the beta-lipoprotein molecule) to the per cent of 
free amino groups succinylated. They found that at a 
ratio of 5/1» 76%> of the free amino groups were 
succinylated; at a ratio of 15/1» 96% of the free amino 
groups were succinylated; and at a ratio of 50/l» 97%> 
of the free amino groups were succinylated. 
In succinylating the 10 grams of beta-lipoprotein 
it was decided to use a ratio of 10/1, since this would 
succinylate about 85%> of the free amino groups. This 
would be much greater than the minimum of 5$ needed to 
prevent precipitation with dextran sulfate, and 
presumably other sulfated mucopolysaccharides. 
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If a ratio of 10/1 is used, then 10 grams of beta- 
lipoprotein require about 0,015 moles of succinic 
anhydride , or 1.5 grams. 
47 
Using the following* 
2.3 grams of beta-lipoprotein/mole 
350 moles of lysine/ mole of beta-lipoprotein 
10 moles of succinic anhydride 
1 mole of lysine 
x 350 moles of lysine 
1 mole of beta-lipoprotein 
x 1 mole of beta-lipoprotein 
2.3 x 10^ grams 
x 10 grams of beta-lipoprotein 
-2 1.52 x 10 moles of succinic anhydride 
= 1.5 grams 
-30- 
. 
RESULTS 
The results of the experiment on 13 sets of vessels 
are shown in tables 2 and 3» 
Table 2 indicates changes in volume of lipoprotein 
solutions in the vessels’ lumens after they were subjected 
to a pressure of J00 mm. Hg for 24 hours. The amount of 
cholesterol in the bathing solution after this 24 hours 
is also given for each trial. Cholesterol and volume 
determinations were carried out on 12 of the 13 trials. 
The amount of cholesterol in the vessel wall was obtained 
by subtracting the cholesterol in the bathing solution 
and the cholesterol in the lumen at the end of the 24 
hours from the initial quantity of cholesterol in the 
lumen of the arterial segments. 
Of the 12 trials on which permeability parameters 
were obtained, 9 of these showed virtually no unmodified 
or modified beta-lipoprotein in their respective bathing 
solutions after 24 hours of exposure in the pressurized 
in vitro test system. Two of the 12 trials (9 and 10) 
showed increased permeability in both vessels, and in 
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one trial (8) there was increased permeability to the 
native beta-lipoprotein but not the succinylated one. 
The volume changes in the lipoprotein solutions 
within the vessel lumen were quite variable. While as 
much as 1.7 mis. of the unmodified and 2.1 mis. of the 
modified samples remained within the lumen on certain 
trials, there were trials when no measurable volume 
was left. 
There was no consistency as to the amount of 
cholesterol that was calculated to be in the vessel 
walls. In 5 of the 12 trials there was more cholesterol 
in the vessel wall exposed to the unmodified beta- 
lipoprotein solution, and in 4 of the 12 trials there 
was more cholesterol in the vessel wall exposed to the 
modified lipoprotein solution. In 3 of the 12 trials 
there was approximately the same quantity (within one 
milligram) of cholesterol in each of the vessel walls. 
The quantity of cholesterol in the vessel wall was 
also quite variable- from 8.0 to 28.5 mg. with vessels 
exposed to the native beta-lipoprotein and from 8.6 
to 31*4 mg. with those exposed to the modified beta- 
lipoprotein. 
On trials 7»8,9» and 10 none of the modified 
lipoprotein solution was left in the vessel lumen after 
the 24 hours at 300 mm. Hg pressure. It was noted that 
the formalin solutions in which these vessels were placed 
after the experiment became quite turbid. Even in those 
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trials where some of the lipoprotein solution remained 
in the vessel lumen after 24 hours, a slight cloudiness 
was noted in the formalin solutions fixing the vessels 
that were exposed to the modified beta-lipoprotein 
solution. In contrast the formalin solutions fixing 
the vessels that were exposed to the unmodified beta- 
lipoprotein solution remained clear in all of the trials. 
Table 3 gives the histologic findings of frozen 
sections of control vessels and the vessels after 
exposure to the lipoprotein solutions in the pressurized, 
in vitro system. This table shows that there was a 
marked difference in the histologic appearance of the 
vessels exposed to the unmodified beta-lipoprotein 
solution and of the corresponding vessels exposed to the 
modified beta-lipoprotein solution. In all 13 trials 
the histology of the vessel subjected to the unmodified 
beta-lipoprotein solution revealed a massive accumulation 
of lipid at the intimal surface with varying degrees 
of penetration into the intima. In only two of the 13 
trials (4 and 7) was there any lipid accumulation at 
the intimal surface with the modified lipoprotein solution. 
In these two instances the sudanophilia was not as 
intense or extensive as that seen with the vessels 
exposed to the unmodified beta-lipoprotein solution. 
In the other 11 trials the vessel exposed to the modified 
lipoprotein solution was histologically comparable in all 
respects to the control. 
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Hematoxylin and eosin stains were done on the 
vessels used in trials 10 and 13. These showed that the 
vessels exposed to the pressurized, in vitro system 
did not lose their cellular or compartmental integrity 
and were comparable to their corresponding control. 
Photomicrographs of representative frozen sections 
stained for lipid from trials 8 and 13 are shown in the 
following pages. 
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DISCUSSION 
The results of the experiment can be discussed in 
terms of differences in the permeability of the native 
and the modified lipoprotein molecules as measured by 
the movement of cholesterol through the vessel wall, 
and in terms of differences in the localization of lipid 
in the vessel wall as demonstrated by the histology of the 
fat stained frozen sections of the vessels. An 
explanation of the turbidity observed in the formalin 
solutions is advanced as an aid in correlating the major 
findings, 
The majority of the trials showed the vessels to 
be quite impermeable to both lipoprotein solutions, as 
measured by the amount of cholesterol in the bathing 
solution. However, there were a few vessels which showed 
increased permeability to the solutions they contained. 
While preliminary testing for leaks was done on all 
vessels used, these instances of increased permeability 
probably arose from minute leaks that went undetected 
in the preliminary screening, or from leaks that 
-A 0 - 

developed during the 24 hours in which the pressure was 
maintained. The histologic findings, which will 
subsequently be discussed in detail, are in agreement 
with this conclusion, as they show no lipid staining 
material beyond the intima into the media and adventitia, 
except in one instance (2-unmodified). Thus the intact 
arterial vessel wall proved to be an effective barrier 
to the passage of both the unmodified and modified 
beta-lipoproteins from the vessel lumen into the bathing 
solution. 
As table 3 indicates the striking histologic 
accumulation of sudanophilic material at the intimal 
surface of the vessels exposed to the native lipoprotein 
solution, but not of those segments exposed to the 
modified lipoprotein solution is a consistent finding. 
This is the most important observation of the experiment, 
as it parallels the in vitro behavior of the modified and 
unmodified beta-lipoproteins in the presence of sulfated 
mucopolysaccharides. Since all other variables were 
the same for both vessels in each trial except for the 
nature of the lipoprotein solution that they contained, 
the histologic difference observed must be explained in 
terms of differences in the modified and unmodified 
lipoprotein solutions themselves. It is not possible 
from the present experiments to characterize the state 
of the lipid observed histologically at the intimal 
surface of vessels exposed to the native lipoprotein- 
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whether it is in the same unbound form as it is in the 
solution, or whether it has reacted with one or more 
components of the intimal connective tissue® Extraction 
and chemical analysis would be necessary. 
However, the possibility exists, based on the known 
in vitro chemistry of these lipoprotein solutions, that 
the observed lipid accumulation is a result of binding 
in the intima or at the intimal surface between the 
native beta-lipoprotein and the sulfated mucopolysaccharides 
of the arterial connective tissue. Beta-lipoproteins 
modified by succinylation, which have lost their 
electrostatic potential to react with sulfated muco¬ 
polysaccharides, accordingly would not be expected to 
be bound at the intimal surface or in the underlying 
subendothelial space. 
The ability of the native beta-lipoprotein to 
combine with the sulfated mucopolysaccharides of the 
intima may be the property which makes beta-lipoproteins 
unique in their ability to initiate the arteriosclerotic 
process. The vessel wall may be quite impermeable to 
large molecules such as the unmodified and modified 
beta-lipoproteins in the sense that these molecules can 
not easily traverse the wall's entire thickness. 
However, given the opportunity to penetrate into the 
intima by the application of extremely high pressure 
or previous vessel wall injury, the native beta-lipoprotein 
may enter the subendothelial compartment and become bound 
-42- 
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by sulfated mucopolysaccharides. Cellular defense 
mechanisms may now come into play in this altered 
intimal state, and the chronic process of arteriosclerosis 
begins. 
On the other hand, the modified beta-lipoprotein 
in such circumstances would remain in the vessel 
lumen, because there are no electrostatic forces between 
the lipoprotein and the sulfated mucopolysaccharides to 
attract the lipoprotein into the intima. Thus these 
proteins would not be expected to act as a stimulus for 
the initiation of the arteriosclerotic response. 
Electron microscopic research on the vessel wall 
of of small blood vessels has revealed a narrow, 
electron dense band that lies between the endothelial 
48 
cell and the vessel lumen. It is not certain 
whether this represents a basement membrane, or whether 
it is just an artifact. With autoradiographic studies 
Curran demonstrated that endothelial cells of small 
capillaries accumulated radioactive , suggesting 
that these cells might secret sulfated mucopolysaccharides 
and that in fact this basement membrane may be composed 
49 
of mucopolysaccharides similar to those in the intima. 
Whether or not this situation holds true for larger 
vessels such as the aorta and the carotids is not known. 
However, if it were so, then this compartment of high 
sulfated mucopolysaccharide concentration may also be 
responsible for some of the lipoprotein binding 
-^3- 
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observed in our experiments® 
Other possibilities could be entertained to explain 
the different histology that was observed in the vessels 
exposed to the two different lipoprotein fractions. 
The accumulation of lipid at the intimal surface that 
was seen with the native beta-lipoprotein may merely be 
precipitation of the protein, an aggregation that is 
catalyzed by surface contact with the vessel wall. The 
altered lipoprotein might be protected against this 
phenomenon because of its different molecular make-up. 
This hypothesis is unlikely for two reasons® First, 
the lipid accumulation did not have the histologic 
appearance of massive protein self-aggregation at the 
intimal surface, and in some instances penetration 
into the intima could be appreciated. It should be 
mentioned that the physical characteristics of the 
unmodified lipoprotein solutions within the vessel 
lumen remained the same throughout the experiments 
and showed no evidence of precipitation. Second, in 
experiments similar to ours Wilens demonstrated 
penetration of lipid through the entire intima in vessels 
containing plasma that were subjected to a pressure 
43 
of 300 mm. Hg for 36-48 hours. 
The incidental finding of turbidity in the formalin 
solutions containing the vessels exposed to the 
modified lipoprotein solution, but not in the formalin 
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solutions containing vessels exposed to the unmodified 
beta-lipoprotein solution has implications in explaining 
the results described. It was concluded that this 
turbidity was due to modified lipoprotein that was 
physically adherent to the vessel wall and was washed 
off and precipitated in the formalin solution. Thus, with 
the vessels subjected to the modified lipoprotein 
solution, some of the cholesterol is accounted for by 
its being loosely attached to the vessel wall; and the 
amount of cholesterol deposited in the vessel wall 
by the modified protein carrier is less than table 2 
indicates. In fact since the histology of vessels 
exposed to the modified beta-lipoprotein solution 
showed no lipid accumulation within the vessel wall 
(except in the two instances mentioned), it would be 
expected that there should be very little cholesterol 
in the vessel wall, and that the amount of cholesterol 
should be much greater for those vessels exposed to 
the native lipoprotein solution. Our permeability 
results did not show any real difference in the amount 
of cholesterol in the vessel wall deposited by the 
unmodified versus the modified beta-lipoprotein. 
However, if the amount of cholesterol that was found 
in the formalin solution were also subtracted from the 
initial quantity of cholesterol in the modified 
beta-lipoprotein solution, these results would very 
45- 
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likely show this expected difference. 
It was noticed that with the unmodified beta- 
lipoprotein lipid deposition was quite marked around 
plaques. It was mentioned in the basic discussion 
of the connective tissue that there is evidence that 
sulfated mucopolysaccharides are found in increased 
31 
amounts in these areas. It would thus not be 
surprising to find intensely staining lipid material in 
these regions of high sulfated mucopolysaccharide 
concentration. 
Other pieces of evidence have been mentioned 
which support the hypothesis that sulfated mucopoly¬ 
saccharides are important in the pathogenesis of 
arteriosclerosis. The increased susceptibility of 
animals with higher intimal concentrations of muco- 
29,30 
polysaccharides , and the increased incorporation 
of radioactive into arteriosclerotic lesions induced 
32 
in rabbits suggest this. The protection of the 
female, presumably by estrogens, could be explained 
by the effect estrogens have been shown to have on 
28 
decreasing mucopolysaccharide synthesis in the intima. 
The recent emphasis that has been given lipids 
and lipoproteins in atherogenesis has tended to 
divert attention from the part that the vessel wall 
plays in this disease. Hyperlipemic states do not 
necessarily cause arteriosclerosis- they may merely 
accelerate it. Arteriosclerosis in the light of 
- 46- 
, 
* 
modern evidence probably results from an interaction 
between ambient plasma lipoproteins and elements in 
the vessel wall, an interaction which is made possible 
through previous vessel wall injury. 
The arterial intima has remained an enigma to 
investigators. It Is paradoxical but in order to study 
the intima and the cellular elements and substances 
that comprise it, it has been necessary to disrupt 
the natural environment of this organ. In doing this 
the actual relationships that exist in the intima 
and the functional sequences that occur in it are 
obscured. Perhaps when the structure and function of 
this minute vessel compartment are understood, an 
unequivocal pathogenesis of arteriosclerosis can be 
defined. 
-47- 
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SUMMARY 
This experiment has studied the permeability 
characteristics of native and of succinylated human 
plasma beta-lipoproteins through human arteries 
in vitro» In the conditions of the experiment the vessels 
were impermeable to both solutions. However, there was 
evidence that cholesterol was bound to any great extent 
only in the vessels exposed to the unmodified beta- 
lipoprotein. Furthermore, the histology of the vessels 
showed this lipid accumulation to be localized at the 
intimal surface with penetration into the first 
subendothelial intimal connective tissue layers. 
An explanation of these findings is advanced on the 
basis of the in vitro reactions of these molecules 
with sulfated mucopolysaccharides. 
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PHOTOMICROGRAPHS 

PHOTOMICROGRAPH 1. Control 13 x40 Sudan IV 
No stigmata of advanced arteriosclerosis. The intima 
is thin, and there are no plaques or areas of lipid 
accumulation except in internal elastic lamina (black 
line). 
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PHOTOMICROGRAPH 2. Control 13 xlOO Sudan IV 
Scattered black dots in intima are probably lipid. 
Internal elastic lamina again clearly outlined as a 
black line. 
50 

PHOTOMICROGRAPH 3» Control 13 x450 Sudan IV 
High power of intima. Large and small black dots 
are scattered lipid in intima. 
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PHOTOMICROGRAPH 4. Unmodified 13 x40 Sudan IV 
Black line at intimal surface is lipid deposited 
from lipoprotein solution. 
' 'SUs. V ^ ' /'-'V. 
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PHOTOMICROGRAPH 5. Modified 13 x40 Sudan IV 
Comparable to control. No lipid deposit at intimal 
-52- 
surface . 
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PHOTOMICROGRAPH 6. Unmodified 13 xlOO Sudan IV 
Lipid at intimal surface is seen with evidence of 
penetration into intima. 
✓ Z1 
PHOTOMICROGRAPH 7. Modified 13 xlOO Sudan IV 
Comparable to control. Intimal surface free of lipid. 
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PHOTOMICROGRAPH 8, Unmodified 13 x45Q Sudan IV 
Sudanophilic material at intimal surface, penetrating 
first few layers of intima. Large black dots are cell nuclei. 
PHOTOMICROGRAPH 9. Modified 13 x45Q Sudan IV 
Comparable to control. No lipid at intimal surface. 
Surface black dots are control lipid. 
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PHOTOMICROGRAPH 10. Control 8 x40 Sudan IV 
Clean vessel with thin intima. Only lipid is in 
internal elastic lamina (black line). 
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PHOTOMICROGRAPH 11. Control 8 xlOO Sudan IV 
No lipid is seen except in internal elastic lamina 
(dark line). 
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PHOTOMICROGRAPH 12, Control 8 x450 Sudan IV 
High power of intima and first few layers of media. 
Only lipid is in internal elastic lamina (dark 
area). 
-57- 
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PHOTOMICROGRAPH 13. Unmodified 8 x40 Sudan IV 
Lipid deposit at intimal surface after exposure to 
unmodified lipoprotein solution. Internal elastic 
lamina also stains for lipid (black). 
PHOTOMICROGRAPH 14, Modified 8 x40 Sudan IV 
Comparable to control. Black line is control lipid in 
internal elastic lamina. 
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PHOTOMICROGRAPH 15. Unmodified 8 xlOO Sudan IV 
Thick lipid deposit at intimal surface. Internal elastic 
lamina is stained darker (control lipid). 
PHOTOMICROGRAPH 16. Modified 8 xlOO Sudan IV 
Comparable to control. Only control lipid (dark line) 
is present in internal elastic lamina. 
59 
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PHOTOMICROGRAPH 17. Unmodified 8 x450 Sudan IV 
Coagulated lipid at intimal surface with scattered 
lipid deposits. 
PHOTOMICROGRAPH 18. Modified 8 x450 Sudan IV 
Comparable to control. No lipid seen at surface or 
in intima. 
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PHOTOMICROGRAPH 19. Unmodified 2 x450 Sudan IV 
Plaque with intense sudanophilic material layered on 
intimal surface. Lipophages and lipid droplets scattered 
in plaque. Slight control sudanophilia of internal 
elastic lamina. 
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